Peripheral nerve elongation trial (Peripheral nerve elongation trial)

Completed

• Conditions: Peripheral nerve disorder

• Registration Number: jRCTs032180098

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-01-28
• Study Start: 2020-07-17
• Last Update Posted: 2022-04-01

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

Patients who injured peripheral nerve defect of limbs 20 years old or more and less than 65 years old

Exclusion Criteria

The diabetic patient who is under medication The patient who have peripheral nerve disorder
The patient who has a serious heart disorder The patient who has a doubt or diagnostic neoplastic lesion within 5 years before agreement The woman that during the pregnancy or the pregnancy is doubted The patient who received other study drugs within current 1 month. The patient who has not ability for agreement with own will. The patient who has not ability for agreement by the reading and writeing The patient who has been judged to be inappropriate as a subject by the doctor incharge

Study & Design

• Study Type: Interventional
• Study Design: single assignment

Primary Outcome Measures

Name	Time	Method
-		Safety of the nerve lengthening method